Pharmacology for Nurses · Thyroid and Parathyroid Disorder Drugs
Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
On this page 9 sections
In 30 seconds
The previous two topics covered thyroid hormone and its control. This topic moves to the second endocrine system managed by glands in the neck: calcium homeostasis. Blood calcium must stay in a narrow range because it drives nerve signaling, muscle contraction (including the heart), blood clotting, and bone structure. When that range is threatened — by parathyroid disease, vitamin D deficiency, kidney disease, or bone disorders such as osteoporosis — clinicians reach for a toolbox of drugs aimed at the same three targets the body itself uses: bone, kidney, and gut.
The classes are: calcium preparations (replacing what is missing), vitamin D (making absorption possible), Bisphosphonates Drugs that bind bone and impair osteoclast bone resorption Full entry → (slowing bone breakdown), Calcimimetics Drugs that activate the parathyroid calcium-sensing receptor, reducing PTH release Full entry → (tricking the parathyroid gland into releasing less PTH), and peptide hormones such as calcitonin and a PTH analog. Because these drugs are often taken for years by older adults — many with several other conditions — nurses need to understand mechanisms, what to monitor, and how to teach people to take them safely. As always, this is an educational overview of classes and mechanisms; doses, schedules, and monitoring must be verified against current references and prescriber orders.
Why this matters
- Osteoporosis is a major public health problem: Fragility fractures — especially hip and vertebral fractures — cause disability and early death in older adults, often in people never diagnosed until the first break. Bisphosphonates and related drugs are the mainstay of prevention and treatment.
- Calcium and vitamin D are everywhere in nursing: From hospital diets to fracture clinics, nurses encounter calcium and vitamin D supplementation constantly — and the two are intertwined, since vitamin D is what allows calcium absorption to happen.
- Parathyroid disease hides in plain sight: Primary hyperparathyroidism is often found incidentally on routine labs. Understanding why PTH matters turns that lab finding into a coherent picture of bone, kidney, and gut effects.
- Long-term drugs need long-term teaching: Bisphosphonates have strict administration rules (empty stomach, upright posture) and rare but serious adverse effects; people on them for years need to know the difference between an inconvenience and a warning sign.
- Kidney disease changes everything: Chronic kidney disease disrupts calcium, phosphate, and vitamin D regulation in ways that calcimimetics and vitamin D analogs are designed to address — a growing area of nursing practice.
The college version
Core Concepts
The calcium balance sheet
Think of calcium as a bank account with three managers:
- Bone is the vault — it holds 99% of the body's calcium and lends it out when blood levels fall.
- Kidney is the accountant — it decides how much calcium to keep (reabsorb) and how much to spend (excrete), and it activates vitamin D.
- Gut is the supplier — it brings dietary calcium in, but only efficiently when vitamin D (as calcitriol) is present.
PTH is the emergency manager: low calcium → PTH rises → bone lends calcium, kidney keeps more, and vitamin D activation increases absorption. Calcitonin opposes bone breakdown. Drugs in this chapter insert themselves into this system at specific points: supplements add supply, vitamin D improves uptake, bisphosphonates slow the lending, calcimimetics quiet the emergency manager, and peptide hormones mimic or replace the body's own signals.
Calcium preparations: adding supply
Calcium supplements provide Elemental calcium The actual amount of calcium mineral in a supplement, regardless of salt form Full entry → — the actual mineral content varies by salt form, which is why two products that look equal by weight are not equal by calcium content. Common forms include Calcium carbonate A calcium salt with high elemental content, best absorbed with food Full entry → (high proportion of elemental calcium, best absorbed with food because it needs stomach acid) and Calcium citrate A calcium salt with lower elemental content, absorbed without food Full entry → (lower proportion, but absorbed without food and better suited to people with reduced stomach acid or certain GI conditions). The mechanism is straightforward: more calcium in the gut raises calcium absorption, supporting blood levels and bone.
Nursing-relevant points: check the elemental calcium content, not just the pill weight; consider timing relative to other medications, because calcium can bind some drugs in the gut and reduce their absorption; and remember that more supplemental calcium is not automatically better — intake targets are individualized. Constipation and GI upset are common complaints worth asking about.
Vitamin D: making absorption possible
Vitamin D is really a prohormone. Sunlight and diet provide it, but the body must convert it in two steps — first in the liver to Calcidiol (25-hydroxyvitamin D) The liver's storage form of vitamin D Full entry →, then in the kidney to Calcitriol (1,25-dihydroxyvitamin D) The active, kidney-activated form of vitamin D Full entry →, the active form that instructs the gut to absorb calcium and phosphate. Drug products include ergocalciferol (D2) and cholecalciferol (D3) (both require activation) and calcitriol itself (already active — used when the activation machinery fails, such as in advanced kidney disease).
The clinical point: measuring "vitamin D" usually means measuring the storage form (25-hydroxyvitamin D), and treating deficiency means replenishing that store. Because calcitriol raises blood calcium, active vitamin D products can cause high calcium if overused — monitoring blood calcium is part of the picture, especially in kidney disease where calcium, phosphate, and PTH are managed together.
Bisphosphonates: slowing bone breakdown
Bisphosphonates — the class includes alendronate, risedronate, ibandronate, and zoledronic acid — are the workhorse anti-resorptive drugs. Their mechanism: they bind to bone mineral and are taken up by Osteoclasts The bone cells that break down (resorb) bone tissue Full entry → (the bone-dissolving cells), interfering with the cells' ability to resorb bone. Over time, bone breakdown slows while formation continues, so bone mass is preserved or increased and fracture risk falls. They are used to treat osteoporosis and to manage bone complications of other diseases under specialist direction.
Administration rules exist for a reason: bisphosphonates are poorly absorbed, and if the tablet lingers in the esophagus it can cause irritation. The standard teaching pattern for oral forms is to take the drug on an empty stomach with plain water, remain upright, and wait before eating or taking other medications — the exact timing is product-specific and must be verified. Rare but serious adverse effects reported with long-term use include Osteonecrosis of the jaw Rare bone death in the jaw reported with long-term antiresorptive therapy Full entry → and atypical femoral fractures; jaw symptoms and dental health should be discussed with the prescriber, especially before planned dental procedures. These are educational descriptions of class-level risk, not diagnostic criteria.
Calcimimetics: quieting the parathyroid gland
Calcimimetics (prototype: cinacalcet) work by a clever mimicry: they bind to the calcium-sensing receptor on parathyroid cells and make the gland "think" blood calcium is higher than it is. The gland therefore releases less PTH, which lowers blood calcium. This class is used in conditions of excess PTH — most notably secondary hyperparathyroidism in chronic kidney disease and in some people with parathyroid cancer or severe primary hyperparathyroidism who cannot have surgery. Because the drug lowers calcium by design, low calcium is the adverse effect to understand and monitor for; symptoms like muscle cramping or tingling should prompt evaluation.
Peptide hormones: calcitonin and PTH analogs
Two peptide hormones work at opposite ends of the bone seesaw:
- Calcitonin (salmon calcitonin) inhibits osteoclast activity, lowering blood calcium and slowing bone breakdown. It is used in selected situations such as treating hypercalcemia or certain bone pain conditions — its role in routine osteoporosis has declined as other options emerged. Because it is a foreign protein, allergic-type reactions are possible, and nasal formulations have their own administration and storage considerations.
- Teriparatide A recombinant PTH fragment that stimulates bone formation when given intermittently Full entry →, a recombinant fragment of PTH, is the opposite strategy: instead of slowing breakdown, it stimulates bone formation. PTH at high continuous levels causes bone loss, but intermittent exposure builds bone — so teriparatide is given as a daily injection, reserved for people at very high fracture risk, with monitoring and limited treatment duration under specialist care. It is a good example of how dose pattern, not just drug identity, determines effect.
Common Confusions
| Do not confuse | With | Difference |
|---|---|---|
| Vitamin D | Calcium | Vitamin D does not add calcium; it enables calcium absorption — deficiency looks like a calcium problem |
| Storage vitamin D (calcidiol) | Active vitamin D (calcitriol) | Most products must be activated by liver and kidney; calcitriol is already active, used when activation fails (e.g., advanced kidney disease) |
| Bisphosphonates (slow bone breakdown) | Teriparatide (builds bone) | Both treat osteoporosis but by opposite mechanisms: antiresorptive vs. anabolic |
| Teriparatide's PTH | Continuous high PTH in hyperparathyroidism | Intermittent PTH exposure builds bone; sustained high PTH (disease) breaks it down — same hormone, opposite effect by pattern |
| Calcimimetics | Calcium supplements | Calcimimetics lower PTH (and thus calcium) by mimicking high calcium; supplements add calcium directly |
| Pill weight | Elemental calcium | A 1,250 mg tablet of one salt may contain far less elemental calcium than a smaller tablet of another |
| Osteoporosis | Osteomalacia | Osteoporosis is loss of bone mass; osteomalacia is poor bone mineralization (often vitamin D deficiency) — different problems, different treatments |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your bones are like a calcium bank, and your blood always needs some calcium on hand for your muscles and nerves. Vitamin D is the key that lets food-calcium get in from your "kitchen" (your gut). Some medicines add more calcium to the kitchen, some unlock the door, some slow down the "bank tellers" who keep lending calcium out of the bones, and one tricks the little gland in your neck into thinking there's plenty of calcium so it stops sending out emergency "get more calcium!" messages.
Worked example
Mrs. P., age 68, has chronic kidney disease and is found on routine labs to have a low blood calcium, a high phosphate, and a rising PTH. Her provider explains the chain: failing kidneys cannot activate vitamin D well, so her gut absorbs less calcium; blood calcium drifts down; her parathyroid glands respond by pouring out PTH to rescue it — the beginning of secondary hyperparathyroidism.
Trace the drug logic step by step:
- Vitamin D (active form): because her kidneys cannot activate vitamin D, an already-active product (calcitriol) bypasses the broken step and restores gut absorption — this is why active vitamin D is the class used in advanced kidney disease.
- Calcium: if dietary intake is insufficient, a calcium preparation adds supply — with attention to elemental content and timing relative to other medications (some bind calcium).
- Calcimimetic: if PTH stays too high despite the above, a calcimimetic quiets the parathyroid gland directly, lowering PTH and therefore the calcium it was trying to mobilize.
Each step is a different manager in the calcium bank: supply (calcium), absorption (vitamin D), and the emergency manager (calcimimetic). The nurse's job across all three is monitoring — labs, symptoms of low calcium (muscle cramping, tingling) — and teaching about medication timing and what to report. Every dose, target, and monitoring interval is verified against the current order, the formulary, and kidney-disease-specific references.
Safety note: This example illustrates drug classes and mechanisms for education. Doses, elemental calcium targets, vitamin D product selection, calcimimetic titration, and monitoring in kidney disease are highly individualized — always verify against current references, the facility formulary, and the prescriber's orders.
Key takeaways
- The calcium system has three managers: bone (storage), kidney (conservation + vitamin D activation), and gut (absorption). PTH coordinates all three when calcium falls.
- Calcium supplements vary in elemental calcium content — check the elemental amount, not the pill weight; some forms need food, and calcium can bind other drugs in the gut (timing separation is often advised).
- Vitamin D must be activated (liver, then kidney) to become calcitriol, the form that drives gut absorption; active vitamin D products are used when activation fails, as in advanced kidney disease.
- Bisphosphonates slow osteoclast bone breakdown and are the mainstay of osteoporosis treatment; oral forms need empty-stomach, upright administration; long-term use carries rare risks (jaw bone problems, atypical femur fractures) worth knowing at class level.
- Calcimimetics make the parathyroid gland "see" more calcium than exists, reducing PTH release and lowering blood calcium — so low calcium is the adverse effect to understand.
- Calcitonin slows bone breakdown; teriparatide (a PTH fragment) builds bone when given intermittently — dose pattern determines the effect.
- Verify everything against current references, the facility formulary, and prescriber orders — doses, elemental calcium targets, administration timing, and monitoring all vary by product and patient.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
Why can vitamin D deficiency cause low calcium even when dietary calcium intake is adequate?
Show answer
Because vitamin D (as calcitriol) is what allows the gut to absorb calcium efficiently — without activation, dietary calcium cannot be absorbed well no matter how much is eaten.
What is the difference between calcium carbonate and calcium citrate in terms of absorption?
Show answer
Carbonate has a higher proportion of elemental calcium but needs stomach acid and is best taken with food; citrate has less elemental calcium per dose but absorbs without food, suiting people with reduced stomach acid or certain GI conditions.
What is the mechanism of action of bisphosphonates, and why are the empty-stomach, upright administration rules important?
Show answer
They bind to bone and impair osteoclast-mediated bone resorption, slowing bone breakdown. The administration rules reduce the risk of esophageal irritation and improve the very poor absorption of the drug.
How does a calcimimetic lower blood calcium, and what adverse effect follows logically from its mechanism?
Show answer
It activates the calcium-sensing receptor on parathyroid cells, making the gland release less PTH; because less PTH means less calcium mobilization, low blood calcium is the logical adverse effect to monitor.
Explain why teriparatide builds bone even though PTH is classically thought of as a bone-breaking hormone.
Show answer
Because the pattern of exposure matters: continuous high PTH (as in disease) drives bone loss, while brief intermittent exposure (as with daily teriparatide injection) stimulates bone-forming cells — same hormone, opposite net effect.
A person on an oral bisphosphonate reports new jaw pain and is scheduled for a tooth extraction. What should they discuss with their prescriber?
Show answer
They should tell the prescriber about the jaw pain and the planned dental procedure before continuing treatment, so the plan can be evaluated — jaw symptoms on long-term antiresorptive therapy warrant discussion (rare osteonecrosis of the jaw is a class-level concern).
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Elemental calcium
- The actual amount of calcium mineral in a supplement, regardless of salt form
- Calcium carbonate
- A calcium salt with high elemental content, best absorbed with food
- Calcium citrate
- A calcium salt with lower elemental content, absorbed without food
- Calcidiol (25-hydroxyvitamin D)
- The liver's storage form of vitamin D
- Calcitriol (1,25-dihydroxyvitamin D)
- The active, kidney-activated form of vitamin D
- Bisphosphonates
- Drugs that bind bone and impair osteoclast bone resorption
- Osteoclasts
- The bone cells that break down (resorb) bone tissue
- Calcimimetics
- Drugs that activate the parathyroid calcium-sensing receptor, reducing PTH release
- Osteonecrosis of the jaw
- Rare bone death in the jaw reported with long-term antiresorptive therapy
- Teriparatide
- A recombinant PTH fragment that stimulates bone formation when given intermittently
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.